Neuroinflammation and α-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunction

Molecular Genetics and Metabolism
Edward I GinnsAmy B Manning-Boğ


Clinical, epidemiological and experimental studies confirm a connection between the common degenerative movement disorder Parkinson's disease (PD) that affects over 1 million individuals, and Gaucher disease, the most prevalent lysosomal storage disorder. Recently, human imaging studies have implicated impaired striatal dopaminergic neurotransmission in early PD pathogenesis in the context of Gaucher disease mutations, but the underlying mechanisms have yet to be characterized. In this report we describe and characterize two novel long-lived transgenic mouse models of Gba deficiency, along with a subchronic conduritol-ß-epoxide (CBE) exposure paradigm. All three murine models revealed striking glial activation within nigrostriatal pathways, accompanied by abnormal α-synuclein accumulation. Importantly, the CBE-induced, pharmacological Gaucher mouse model replicated this change in dopamine neurotransmission, revealing a markedly reduced evoked striatal dopamine release (approximately 2-fold) that indicates synaptic dysfunction. Other changes in synaptic plasticity markers, including microRNA profile and a 24.9% reduction in post-synaptic density size, were concomitant with diminished evoked dopamine release following CBE exposur...Continue Reading


Feb 1, 1992·The Journal of Cell Biology·M K BennettR H Scheller
Aug 1, 1986·Annals of Neurology·E M KayeJ A Barranger
Feb 1, 1995·Molecular and Chemical Neuropathology·R WillemsenR C Mulligan
Sep 5, 1994·FEBS Letters·D Roth, R D Burgoyne
Mar 25, 1993·Nature·T SöllnerJ E Rothman
Sep 1, 1996·QJM : Monthly Journal of the Association of Physicians·O NeudorferA Zimran
Apr 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·Y LiuR L Proia
Jun 22, 1999·Journal of Neuropathology and Experimental Neurology·K HatanpääS I Rapoport
Jun 14, 2000·Neuroreport·B Hauss-WegrzyniakG L Wenk
Aug 18, 2001·Molecular Genetics and Metabolism·N TayebiE Sidransky
Jan 11, 2003·American Journal of Medical Genetics. Part a·Judit VárkonyiEllen Sidransky
Jan 20, 2004·Molecular Genetics and Metabolism·Alicia LwinEllen Sidransky
Jul 6, 2004·Molecular Genetics and Metabolism·Kondi WongRaphael Schiffmann
Oct 7, 2004·Molecular Genetics and Metabolism·Ellen Sidransky
Dec 14, 2004·Journal of Medical Genetics·O Goker-AlpanE Sidransky
Sep 9, 2005·Neurology·Judith Aharon-PeretzRuth Gershoni-Baruch
Nov 5, 2005·Cell·Sreeganga ChandraThomas C Südhof
May 3, 2006·Blood Cells, Molecules & Diseases·Assaf HalperinAri Zimran
Oct 19, 2006·Journal of Biomedicine & Biotechnology·Kathleen S HruskaEllen Sidransky
Dec 21, 2006·Cancer Research·Yuri PekarskyCarlo M Croce
Sep 20, 2007·JAMA : the Journal of the American Medical Association·John L ZellerRichard M Glass
May 24, 2008·Biochimica Et Biophysica Acta·Verena Aumiller, Klaus Förstemann
Aug 2, 2008·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Christian BarbatoCarlo Cogoni
Nov 22, 2008·Biochemical Society Transactions·Ian G CannellMartin Bushell
Feb 26, 2009·Cell·Richard W Carthew, Erik J Sontheimer
Mar 17, 2009·Brain : a Journal of Neurology·Juliane NeumannNicholas W Wood
May 9, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·John DePaoloEllen Sidransky
Jun 16, 2009·Lancet·Andrew J LeesTamas Revesz
Jul 3, 2009·Journal of Vascular Research·Chandan K SenSashwati Roy
Jan 29, 2010·The Journal of Biological Chemistry·Epaminondas Doxakis
Jun 11, 2010·Brain : a Journal of Neurology·Pablo Garcia-ReitböckMaria Grazia Spillantini
Jul 30, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Satoshi KonoHiroaki Miyajima
Sep 15, 2010·Acta Neuropathologica·Ozlem Goker-AlpanEllen Sidransky
Oct 13, 2010·Journal of Geriatric Psychiatry and Neurology·Lynn M BekrisCyrus P Zabetian
Sep 21, 2011·The Journal of Cell Biology·Giordano LippiKenneth W Young
Dec 14, 2011·Proceedings of the National Academy of Sciences of the United States of America·Massimiliano AgostiniGerry Melino
Feb 9, 2012·Neuro-degenerative Diseases·Scott E CountsElliott J Mufson
Feb 9, 2012·Neurochemical Research·Jagadeesh S RaoEdmund A Reese
May 9, 2012·Brain : a Journal of Neurology·Einat B VitnerAnthony H Futerman

❮ Previous
Next ❯


Sep 30, 2014·Neuroscience Letters·S N PchelinaE Yu Zakharova
Apr 16, 2015·Biomolecules·Tomás Lopes da FonsecaTiago Fleming Outeiro
Jan 9, 2016·Neurochemistry International·Melinda BarkhuizenAnne F Grobler
Dec 1, 2015·Journal of Neurochemistry·Trevor TysonPatrik Brundin
May 20, 2015·Best Practice & Research. Clinical Endocrinology & Metabolism·Deborah ElsteinAri Zimran
Apr 17, 2015·Molecular Neurodegeneration·Davide ChiasseriniTommaso Beccari
Oct 30, 2014·Brain : a Journal of Neurology·Ianai FishbeinRobert L Nussbaum
Jul 6, 2014·Molecular Neurobiology·H ZhangH Yang
May 29, 2016·The Journal of Pathology·Ayelet VardiAnthony H Futerman
Oct 7, 2016·Frontiers in Endocrinology·Matheus Trovão QueirozVânia D'Almeida
Oct 16, 2014·Proceedings of the National Academy of Sciences of the United States of America·Michelle RothaugJudith Blanz
Dec 17, 2014·Acta Neuropathologica Communications·Rosa Giráldez-PérezAmelia Sánchez-Capelo
May 19, 2017·Human Molecular Genetics·Federico N SoriaPierre-Olivier Fernagut
Feb 1, 2018·The FEBS Journal·Matthew E Gegg, Anthony H V Schapira
Mar 1, 2020·Biomolecules·Valeria De PasqualeMarianna Caterino
Jun 4, 2020·Biomolecules·Margarita M IvanovaOzlem Goker-Alpan
Jul 18, 2020·Reviews in the Neurosciences·Tommaso SchirinziLuca Marsili
Aug 24, 2017·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C H AdlerJ G Hentz
Sep 22, 2017·Diseases·Mario de la MataManuel Oropesa-Ávila
Oct 20, 2018·Scientific Reports·Farzaneh AtashrazmNicolas Dzamko
May 7, 2020·Frontiers in Aging Neuroscience·Micol AvenaliSilvia Cerri
Sep 18, 2016·Journal of Neuroscience Research·Ludovico Cantuti-Castelvetri, Ernesto R Bongarzone
Apr 30, 2016·Human Molecular Genetics·Edward RockensteinS Pablo Sardi
Jul 4, 2018·Journal of Parkinson's Disease·David J McGeeElizabeth A Disbrow
Jul 25, 2019·Journal of Neuroinflammation·Penelope J HallettOle Isacson
Apr 7, 2019·Molecular Neurodegeneration·Marie-Eve TremblayLaura Civiero
Feb 20, 2020·Movement Disorders : Official Journal of the Movement Disorder Society·Tanya SimuniUNKNOWN Parkinson's Progression Markers Initiative Investigators
Apr 20, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Anthony H V SchapiraLucilla Parnetti
Mar 17, 2018·Frontiers in Neurology·Paola ImbrianiAntonio Pisani
Mar 18, 2020·Acta Neuropsychiatrica·Anisa Chowdhury, Anto P Rajkumar
May 16, 2017·Advanced Drug Delivery Reviews·Melani Solomon, Silvia Muro
Jun 3, 2021·International Journal of Molecular Sciences·Panagiota Mavroeidi, Maria Xilouri
May 18, 2021·Journal of Parkinson's Disease·Avner ThalerAnat Mirelman
Aug 31, 2021·Journal of Parkinson's Disease·Seok Jong ChungYun Joong Kim
Sep 17, 2021·Essays in Biochemistry·Sarah M Brooker, Dimitri Krainc
Sep 18, 2017·Molecular Genetics and Metabolism·Shahzeb HassanNahid Tayebi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.


Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Astrocytes in Parkinson Disease

Parkinson's disease (PD) is a neurodegenerative disorder caused by the progressive loss of dopaminergic neurons. Some PD-genes may be associated with astrocyte dysfunction. Discover the latest research on astrocytes in Parkinson's disease here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Atypical Parkinsonism (MDS)

Atypical Parkinsonism presents with the same signs and symptoms of Parkinson's disease, but do not respond to typical Parkionson's disease treatment with levodopa. Atypical Parkinsonism is thought to be associated with abnormal protein buildup within brain cells. Here is the latest on Atypical Parkinsonism.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Related Papers

Science Translational Medicine
Ted M Dawson, Valina L Dawson
Lancet Neurology
Ellen Sidransky, Grisel Lopez
Trends in Molecular Medicine
Gabriela MercadoClaudio Hetz
© 2021 Meta ULC. All rights reserved